Phase 1/2a Trial of Pf GAP p52-/p36- Sporozoite Malaria Vaccine

This study has been terminated.
Information provided by (Responsible Party):
Seattle Biomedical Research Institute Identifier:
First received: December 1, 2009
Last updated: May 28, 2013
Last verified: May 2013
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2011
  Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)
No publications provided by Seattle Biomedical Research Institute

Publications automatically indexed to this study by Identifier (NCT Number):